Zurueck zur Suche

Reporte zur Charge U6971AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KY 1

VAERS 2267198

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge U6971AA

gering
Staat
KY
Alter
1,5
Geschlecht
F
Eingang
09.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Medication error No adverse event Wrong product administered

Symptomtext

18 month old got Pentacel, including the polio, that was not due with no reported adverse event; Initial information was received on 04-May-2022 regarding an unsolicited valid non-serious case received from a health professional. This case involves a 18 months old female patient who got pentacel, including the polio, that was not due with no reported adverse event while receiving vaccine diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included: Pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13) for Prophylactic vaccination. On 03-May-2022, the patient received 4th dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [pentacel] 0.5 ml (Batch number: U6971AA, expiration date: 11-Sep-2022) via intramuscular route in the left thigh for prophylactic vaccination. On 03-May-2022 the patient got pentacel, including the polio, that was not due with no reported adverse event (wrong product administered) (latency: on the same day) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [pentacel]. Action taken: Not applicable. Corrective treatment: Not reported. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR 13
Allergien
-
Vorherige Impfungen
-